> top > docs > PMC:7091888 > spans > 0-1536 > annotations

PMC:7091888 / 0-1536 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 57-79 Species denotes 2019 novel coronavirus Tax:2697049
30 839-870 Gene denotes angiotensin-converting enzyme 2 Gene:59272
31 872-876 Gene denotes ACE2 Gene:59272
32 955-959 Gene denotes ACE2 Gene:59272
33 1076-1080 Gene denotes ACE2 Gene:59272
34 525-530 Gene denotes spike Gene:43740568
35 766-767 Gene denotes S Gene:43740568
36 405-452 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
37 454-464 Species denotes SARS-CoV-2 Tax:2697049
38 481-503 Species denotes 2019 novel coronavirus Tax:2697049
39 505-514 Species denotes 2019-nCoV Tax:2697049
40 521-524 Species denotes CoV Tax:11118
41 755-765 Species denotes SARS-CoV-2 Tax:2697049
42 825-830 Species denotes human Tax:9606
43 889-899 Species denotes SARS-CoV-2 Tax:2697049
44 974-982 Species denotes SARS-CoV Tax:694009
45 1041-1051 Species denotes SARS-CoV-2 Tax:2697049
46 1060-1068 Species denotes SARS-CoV Tax:694009
47 1146-1154 Species denotes SARS-CoV Tax:694009
48 1202-1212 Species denotes SARS-CoV-2 Tax:2697049
49 1230-1238 Species denotes SARS-CoV Tax:694009
50 1283-1293 Species denotes SARS-CoV-2 Tax:2697049
51 1331-1339 Species denotes SARS-CoV Tax:694009
52 1377-1387 Species denotes SARS-CoV-2 Tax:2697049
53 194-218 Disease denotes Coronavirus Disease 2019 MESH:C000657245
54 220-228 Disease denotes COVID-19 MESH:C000657245
55 371-380 Disease denotes infection MESH:D007239
56 1121-1130 Disease denotes infection MESH:D007239
57 1392-1410 Disease denotes SARS-CoV infection MESH:C000657245
92 1450-1455 Species denotes human Tax:9606
93 1456-1469 Species denotes coronaviruses Tax:11118
94 1471-1475 Species denotes CoVs Tax:11118

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 116-123 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T2 535-542 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T3 768-775 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T4 799-806 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T5 1092-1097 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T6 1139-1144 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T7 1217-1224 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 194-218 Disease denotes Coronavirus Disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T2 220-228 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 371-380 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T4 405-452 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T5 405-438 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T6 454-462 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T7 454-458 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T8 755-763 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T9 755-759 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T10 889-897 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 889-893 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T12 974-982 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T13 974-978 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T14 1041-1049 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T15 1041-1045 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T16 1060-1068 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T17 1060-1064 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T18 1121-1130 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T19 1146-1154 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T20 1146-1150 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T21 1202-1210 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T22 1202-1206 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T23 1230-1238 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T24 1230-1234 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T25 1283-1291 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T26 1283-1287 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T27 1331-1339 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T28 1331-1335 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T29 1377-1385 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T30 1377-1381 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T31 1392-1410 Disease denotes SARS-CoV infection http://purl.obolibrary.org/obo/MONDO_0005091
T32 1392-1396 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T33 1401-1410 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 127-128 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 230-233 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T3 240-241 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 627-628 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 825-830 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T6 835-838 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bat
T7 1092-1097 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8 1139-1144 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9 1450-1455 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 116-123 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T2 146-155 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T3 535-542 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T4 673-683 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T5 768-775 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T6 799-806 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T7 839-850 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T8 1217-1224 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-167 Sentence denotes Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
T2 169-177 Sentence denotes Abstract
T3 178-516 Sentence denotes The outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV).
T4 517-697 Sentence denotes The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines.
T5 698-888 Sentence denotes Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S protein and found that the RBD protein bound strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors.
T6 889-1145 Sentence denotes SARS-CoV-2 RBD exhibited significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD and could block the binding and, hence, attachment of SARS-CoV-2 RBD and SARS-CoV RBD to ACE2-expressing cells, thus inhibiting their infection to host cells.
T7 1146-1411 Sentence denotes SARS-CoV RBD-specific antibodies could cross-react with SARS-CoV-2 RBD protein, and SARS-CoV RBD-induced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.
T8 1413-1425 Sentence denotes Introduction